A detailed history of Pier 88 Investment Partners LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 37,500 shares of RCKT stock, worth $328,500. This represents 0.62% of its overall portfolio holdings.

Number of Shares
37,500
Previous 32,490 15.42%
Holding current value
$328,500
Previous $600,000 21.5%
% of portfolio
0.62%
Previous 0.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$11.35 - $18.82 $56,863 - $94,288
5,010 Added 15.42%
37,500 $471,000
Q3 2024

Nov 05, 2024

BUY
$17.6 - $25.88 $27,984 - $41,149
1,590 Added 5.15%
32,490 $600,000
Q2 2024

Aug 06, 2024

BUY
$20.66 - $26.72 $266,514 - $344,688
12,900 Added 71.67%
30,900 $665,000
Q3 2023

Nov 09, 2023

BUY
$15.07 - $24.05 $271,260 - $432,900
18,000 New
18,000 $368,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $663M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.